Decision-making for patients with resectable breast cancer: Individualized decisions for and by patients and their physicians

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 1, Issue 2, 2003, Pages 189-196

  Loprinzi, Charles L ^a   Ravdin, Peter M ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Adjuvant therapy; Adjuvant!; Breast cancer; Numeracy; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADJUVANT CHEMOTHERAPY; BREAST TUMOR; DECISION SUPPORT SYSTEM; FEMALE; HUMAN; PATIENT ATTITUDE; PRACTICE GUIDELINE; REVIEW;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DECISION MAKING, COMPUTER-ASSISTED; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PRACTICE GUIDELINES AS TOPIC;

EID: 25144463377     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2003.0017     Document Type: Article

References (18)

1. Levine MN, Gafni A, Markham B et al. A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med 1992;117:53-58.
2. Whelan T. Levine M, Gafni A et al. Mastectomy or lumpectomy? Helping women make informed choices. J Clin Oncol 1999;17:1727-1735, 1999.
3. Whelan TJ, Levine MN, Gafni A et al. Breast irradiation postlumpectomy: Development and evaluation of a decision instrument. J Clin Oncol 1995;13:847-853.
4. Cole BF, Gelber RD, Gelber S et al. Polychemotherapy for early breast cancer: An overview of the randomized clinical trials with quality-adjusted survival analysis. Lancet 2001;358: 277-286.
5. Ravdin PM, Siminoff LA, Davis GJ et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 2001;19:980-991.
6. Loprinzi CL, Thome SD. Understanding the utility of adjuvant systemic therapy for primary breast cancer. J Clin Oncol 2001;19:972-979.
7. Baum M, Ravdin PM. Decision-making in early breast cancer: Guidelines and decision tools. Eur J Cancer 2002;38:745-749.
8. Adjuvant Therapy for Breast Cancer. NIH Consensus Statement Online 2000;17:1-23. http://consensus.nih.gov
9. Carlson RW, Anderson BO, Bensinger W et al. National Comprehensive Cancer Network. NCCN Practice Guidelines for Breast Cancer. Oncology 2000;14:33-49.
10. Goldhirsch A, Glick JH, Gelber RD et al. Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. J Clin Oncol 2001;19:3817-3827.
11. nd ed). Philadelphia: Lippincott Williams & Wilkins, 2000:449-454.
12. Loprinzi CL, Ravdin PM, de Laurentiis M et al. Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer? J Clin Oncol 1994;12:1422-1426.
13. National Cancer Institute. Surveillence, Epidemiology, and End Results. http://www-seer.ims.nci,nih.gov/
14. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. J Clin Oncol 2001;19: 1865-1878.
15. Anonymous. Polychemotherapy for early breast cancer: An overview of the randomized trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1998;352:930-942.
16. Anonymous: Tamoxifen for early breast cancer: An overview of randomized trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1998;351:1451-1467.
17. Ravdin RM, Siminoff L, Hewlett J, et al. Evaluation of impact of communication tool generated by the computer program, Adjuvant!, on patients with early breast cancer and their doctors (Abstr. #119). Proc ASCO 2001;20:31a.
18. Ravdin PM, Siminoff IA, Harvey JA. Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. J Clin Oncol 1998;16:515-521.